Literature DB >> 28886261

Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148.

Konstantin Tsoyi1, Sarah G Chu1, Nasly G Patino-Jaramillo2, Julie Wilder2, Julian Villalba1,2, Melanie Doyle-Eisele2, Jacob McDonald2, Xiaoli Liu1, Souheil El-Chemaly1, Mark A Perrella1, Ivan O Rosas1,2.   

Abstract

Radiation-induced pulmonary fibrosis is a severe complication of patients treated with thoracic irradiation. We have previously shown that syndecan-2 reduces fibrosis by exerting alveolar epithelial cytoprotective effects. Here, we investigate whether syndecan-2 attenuates radiation-induced pulmonary fibrosis by inhibiting fibroblast activation. C57BL/6 wild-type mice and transgenic mice that overexpress human syndecan-2 in alveolar macrophages were exposed to 14 Gy whole-thoracic radiation. At 24 weeks after irradiation, lungs were collected for histological, protein, and mRNA evaluation of pulmonary fibrosis, profibrotic gene expression, and α-smooth muscle actin (α-SMA) expression. Mouse lung fibroblasts were activated with transforming growth factor (TGF)-β1 in the presence or absence of syndecan-2. Cell proliferation, migration, and gel contraction were assessed at different time points. Irradiation resulted in significantly increased mortality and pulmonary fibrosis in wild-type mice that was associated with elevated lung expression of TGF-β1 downstream target genes and cell death compared with irradiated syndecan-2 transgenic mice. In mouse lung fibroblasts, syndecan-2 inhibited α-SMA expression, cell contraction, proliferation, and migration induced by TGF-β1. Syndecan-2 attenuated phosphoinositide 3-kinase/serine/threonine kinase/Rho-associated coiled-coil kinase signaling and serum response factor binding to the α-SMA promoter. Syndecan-2 attenuates pulmonary fibrosis in mice exposed to radiation and inhibits TGF-β1-induced fibroblast-myofibroblast differentiation, migration, and proliferation by down-regulating phosphoinositide 3-kinase/serine/threonine kinase/Rho-associated coiled-coil kinase signaling and blocking serum response factor binding to the α-SMA promoter via CD148. These findings suggest that syndecan-2 has potential as an antifibrotic therapy in radiation-induced lung fibrosis.

Entities:  

Keywords:  fibroblast; myofibroblast; pulmonary fibrosis; radiation; syndecan-2

Mesh:

Substances:

Year:  2018        PMID: 28886261      PMCID: PMC5805997          DOI: 10.1165/rcmb.2017-0088OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  46 in total

Review 1.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

Review 2.  Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.

Authors:  Søren M Bentzen
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

3.  Serum response factor binding sites differ in three human cell types.

Authors:  Sara J Cooper; Nathan D Trinklein; Loan Nguyen; Richard M Myers
Journal:  Genome Res       Date:  2007-01-02       Impact factor: 9.043

4.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

Authors:  Yong Zhou; Xiangwei Huang; Louise Hecker; Deepali Kurundkar; Ashish Kurundkar; Hui Liu; Tong-Huan Jin; Leena Desai; Karen Bernard; Victor J Thannickal
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

Review 5.  Major apoptotic mechanisms and genes involved in apoptosis.

Authors:  Yağmur Kiraz; Aysun Adan; Melis Kartal Yandim; Yusuf Baran
Journal:  Tumour Biol       Date:  2016-04-09

6.  A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats.

Authors:  S Tada; H Iwamoto; M Nakamuta; R Sugimoto; M Enjoji; Y Nakashima; H Nawata
Journal:  J Hepatol       Date:  2001-04       Impact factor: 25.083

7.  Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells.

Authors:  Jasminka Omerovic; Michael J Clague; Ian A Prior
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

8.  Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation.

Authors:  Sandra B Haudek; Damon Gupta; Oliver Dewald; Robert J Schwartz; Lei Wei; JoAnn Trial; Mark L Entman
Journal:  Cardiovasc Res       Date:  2009-04-30       Impact factor: 10.787

Review 9.  Pulmonary complications of radiation therapy.

Authors:  Raymond P Abratt; Graeme W Morgan; Gerard Silvestri; Paul Willcox
Journal:  Clin Chest Med       Date:  2004-03       Impact factor: 2.878

10.  Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis.

Authors:  J N Finkelstein; C J Johnston; R Baggs; P Rubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-02-01       Impact factor: 7.038

View more
  23 in total

1.  Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

Authors:  Keiko Takahashi; Rachel H Kim; Lejla Pasic; Lilly He; Shinya Nagasaka; Daisuke Katagiri; Tracy May; Akira Shimizu; Raymond C Harris; Raymond L Mernaugh; Takamune Takahashi
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

2.  Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness.

Authors:  Konstantin Tsoyi; Juan C Osorio; Sarah G Chu; Isis E Fernandez; Sergio Poli De Frias; Lynette Sholl; Ye Cui; Carmen S Tellez; Jill M Siegfried; Steven A Belinsky; Mark A Perrella; Souheil El-Chemaly; Ivan O Rosas
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

3.  Targeting the renin-angiotensin-aldosterone system in fibrosis.

Authors:  Mohammad AlQudah; Taben M Hale; Michael P Czubryt
Journal:  Matrix Biol       Date:  2020-05-16       Impact factor: 11.583

Review 4.  Tissue-informed engineering strategies for modeling human pulmonary diseases.

Authors:  Kolene E Bailey; Michael L Floren; Tyler J D'Ovidio; Steven R Lammers; Kurt R Stenmark; Chelsea M Magin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

5.  MiRNA-21 functions in ionizing radiation-induced epithelium-to-mesenchymal transition (EMT) by downregulating PTEN.

Authors:  Zheng Liu; Xin Liang; Xueping Li; Xiaodan Liu; Maoxiang Zhu; Yongqing Gu; Pingkun Zhou
Journal:  Toxicol Res (Camb)       Date:  2019-02-28       Impact factor: 3.524

6.  CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.

Authors:  Konstantin Tsoyi; Xiaoliang Liang; Giulia De Rossi; Stefan W Ryter; Kevin Xiong; Sarah G Chu; Xiaoli Liu; Bonna Ith; Lindsay J Celada; Freddy Romero; Matthew J Robertson; Anthony J Esposito; Sergio Poli; Souheil El-Chemaly; Mark A Perrella; YuanYuan Shi; James Whiteford; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

Review 7.  Syndecan receptors: pericellular regulators in development and inflammatory disease.

Authors:  Sandeep Gopal; Samantha Arokiasamy; Csilla Pataki; James R Whiteford; John R Couchman
Journal:  Open Biol       Date:  2021-02-10       Impact factor: 6.411

8.  Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.

Authors:  Maurizio Cutolo; Barbara Ruaro; Paola Montagna; Renata Brizzolara; Emanuela Stratta; Amelia Chiara Trombetta; Stefano Scabini; Pier Paolo Tavilla; Aurora Parodi; Claudio Corallo; Nicola Giordano; Sabrina Paolino; Carmen Pizzorni; Alberto Sulli; Vanessa Smith; Stefano Soldano
Journal:  Arthritis Res Ther       Date:  2018-05-02       Impact factor: 5.156

9.  Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli.

Authors:  Amos E Dodi; Iyabode O Ajayi; Christine Chang; Meghan Beard; Shanna L Ashley; Steven K Huang; Victor J Thannickal; Daniel J Tschumperlin; Thomas H Sisson; Jeffrey C Horowitz
Journal:  Respir Res       Date:  2018-05-10

Review 10.  Advances in Molecular Mechanisms and Treatment of Radiation-Induced Pulmonary Fibrosis.

Authors:  Zhongjie Chen; Zhiqiang Wu; Wen Ning
Journal:  Transl Oncol       Date:  2018-10-17       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.